KK
IRWD icon

KLP Kapitalforvaltning’s Ironwood Pharmaceuticals IRWD Stock Holding History

KLP Kapitalforvaltning’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$611K Hold
174,200
– – ﹤0.01% 1325
2025
Q4 		$587K Hold
174,200
– – ﹤0.01% 1332
2025
Q3 		$228K Hold
174,200
– – ﹤0.01% 1773
2025
Q2 		$125K Sell
174,200
-24,200
-12% -$19K ﹤0.01% 1966
2025
Q1 		$292K Buy
198,400
+174,200
+720% +$415K ﹤0.01% 1575
2024
Q4 		$107K Buy
+24,200
New +$98.2K ﹤0.01% 2058

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KLP Kapitalforvaltning's IRWD Position: Q1 2026 in Review

KLP Kapitalforvaltning held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 174,200 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

KLP Kapitalforvaltning first reported a position in IRWD in Q4 2024 and has held it in 6 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • KLP Kapitalforvaltning held 174,200 shares of Ironwood Pharmaceuticals worth $611K as of Q1 2026.
  • KLP Kapitalforvaltning left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1325 holding.
  • KLP Kapitalforvaltning first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.